AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2024
Sep 24, 2024
34519_dirs_2024-09-24_25fba44d-6893-4056-a68c-b8abe7bca8a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2024-09-20
Reporting Person: Tomsche David Scott (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-20 | Non Qualified Stock Options (Right to buy) | $3.60 | A | 10000 | Acquired | 2029-09-20 | Common Stock (10000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23